Clinical Trial Update: An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy [Phase 4]

View source ↗

Summary

Phase 4 open-label study of golodirsen in non-ambulant Duchenne muscular dystrophy patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Golodirsen (golodirsen)

Snippet

Sponsor: Rare Disease Research, LLC | Conditions: Duchenne Muscular Dystrophy | Phase 4 | Status: TERMINATED